 Marc Goalstone
Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alkyl and Aryl Transferases | 21 | 2016 | 52 | 2.650 |
Why?
| | Insulin | 31 | 2016 | 2447 | 1.600 |
Why?
| | Mitogen-Activated Protein Kinase 7 | 4 | 2014 | 20 | 1.290 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 15 | 2003 | 262 | 1.210 |
Why?
| | Protein Prenylation | 14 | 2016 | 34 | 0.990 |
Why?
| | Muscle, Smooth, Vascular | 5 | 2007 | 450 | 0.610 |
Why?
| | Adipocytes | 6 | 2005 | 227 | 0.590 |
Why?
| | Hyperinsulinism | 8 | 2004 | 122 | 0.570 |
Why?
| | Receptor, Insulin | 6 | 2005 | 100 | 0.520 |
Why?
| | Farnesyltranstransferase | 14 | 2007 | 35 | 0.510 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 42 | 0.430 |
Why?
| | Platelet-Derived Growth Factor | 4 | 2003 | 92 | 0.380 |
Why?
| | Insulin-Like Growth Factor I | 6 | 2002 | 325 | 0.360 |
Why?
| | Enzyme Activation | 10 | 2016 | 819 | 0.350 |
Why?
| | Aorta | 1 | 2014 | 416 | 0.350 |
Why?
| | 3T3 Cells | 10 | 2003 | 164 | 0.340 |
Why?
| | Insulin-Secreting Cells | 2 | 2016 | 374 | 0.320 |
Why?
| | Myogenic Regulatory Factors | 2 | 2007 | 55 | 0.310 |
Why?
| | Phosphorylation | 14 | 2007 | 1767 | 0.300 |
Why?
| | Endothelium, Vascular | 2 | 2014 | 935 | 0.300 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1244 | 0.290 |
Why?
| | Transferases | 4 | 1997 | 31 | 0.290 |
Why?
| | Angiotensin II | 2 | 2007 | 98 | 0.290 |
Why?
| | Oocytes | 3 | 2000 | 179 | 0.290 |
Why?
| | Glucose | 4 | 2016 | 1031 | 0.290 |
Why?
| | Rats | 10 | 2016 | 5591 | 0.290 |
Why?
| | Endothelial Cells | 1 | 2014 | 790 | 0.290 |
Why?
| | Xenopus laevis | 3 | 2000 | 107 | 0.290 |
Why?
| | Enzyme Inhibitors | 11 | 2011 | 850 | 0.280 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2005 | 145 | 0.270 |
Why?
| | Cell Division | 5 | 2002 | 794 | 0.240 |
Why?
| | Hypoglycemic Agents | 4 | 2011 | 1343 | 0.240 |
Why?
| | Hippocampus | 1 | 2011 | 929 | 0.240 |
Why?
| | Adipogenesis | 1 | 2005 | 57 | 0.230 |
Why?
| | Animals | 29 | 2016 | 37243 | 0.230 |
Why?
| | ras Proteins | 3 | 2005 | 148 | 0.220 |
Why?
| | Androstadienes | 4 | 2011 | 78 | 0.200 |
Why?
| | rhoA GTP-Binding Protein | 6 | 2003 | 87 | 0.200 |
Why?
| | Signal Transduction | 5 | 2014 | 5092 | 0.190 |
Why?
| | Neurons | 1 | 2011 | 1602 | 0.190 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2001 | 46 | 0.170 |
Why?
| | Flavonoids | 3 | 2007 | 85 | 0.160 |
Why?
| | Guanosine Triphosphate | 3 | 2000 | 90 | 0.150 |
Why?
| | Receptor, IGF Type 1 | 2 | 1998 | 64 | 0.150 |
Why?
| | Epidermal Growth Factor | 2 | 1998 | 176 | 0.150 |
Why?
| | GTP-Binding Proteins | 1 | 1999 | 152 | 0.140 |
Why?
| | Protein Subunits | 4 | 2007 | 242 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2001 | 429 | 0.140 |
Why?
| | Mice | 13 | 2005 | 17828 | 0.140 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 276 | 0.140 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 174 | 0.130 |
Why?
| | RNA, Small Interfering | 2 | 2011 | 626 | 0.120 |
Why?
| | Down-Regulation | 2 | 2011 | 636 | 0.120 |
Why?
| | Transfection | 5 | 2001 | 942 | 0.120 |
Why?
| | Breast Neoplasms | 4 | 2003 | 2283 | 0.120 |
Why?
| | Proteolysis | 1 | 2016 | 176 | 0.120 |
Why?
| | Caspase 3 | 1 | 2016 | 251 | 0.120 |
Why?
| | Cells, Cultured | 6 | 2011 | 4182 | 0.120 |
Why?
| | Cell Nucleus | 2 | 2011 | 608 | 0.120 |
Why?
| | Proteins | 1 | 2001 | 1009 | 0.110 |
Why?
| | Stress, Physiological | 1 | 2016 | 450 | 0.100 |
Why?
| | NF-kappa B | 2 | 2011 | 678 | 0.100 |
Why?
| | Insulin Receptor Substrate Proteins | 3 | 2003 | 60 | 0.100 |
Why?
| | src Homology Domains | 2 | 2003 | 39 | 0.090 |
Why?
| | Insulin Resistance | 4 | 2005 | 1222 | 0.090 |
Why?
| | Liver | 2 | 2001 | 1807 | 0.090 |
Why?
| | Cell Differentiation | 4 | 2005 | 1994 | 0.090 |
Why?
| | Immunoprecipitation | 1 | 2011 | 155 | 0.090 |
Why?
| | Kinetics | 3 | 2001 | 1649 | 0.090 |
Why?
| | Drug Synergism | 6 | 2003 | 367 | 0.080 |
Why?
| | Cytoplasm | 1 | 2011 | 270 | 0.080 |
Why?
| | Models, Biological | 4 | 2016 | 1810 | 0.080 |
Why?
| | Obesity | 2 | 2005 | 2994 | 0.080 |
Why?
| | Phosphoproteins | 3 | 2003 | 340 | 0.080 |
Why?
| | Muscle, Skeletal | 2 | 2001 | 1734 | 0.080 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2009 | 15 | 0.080 |
Why?
| | Drug Interactions | 1 | 2011 | 404 | 0.080 |
Why?
| | Cell Membrane | 3 | 1998 | 716 | 0.080 |
Why?
| | Polyisoprenyl Phosphates | 2 | 2001 | 6 | 0.080 |
Why?
| | Amyloid beta-Peptides | 1 | 2011 | 230 | 0.070 |
Why?
| | Sesquiterpenes | 2 | 2001 | 55 | 0.070 |
Why?
| | Cell Line | 3 | 2009 | 2879 | 0.070 |
Why?
| | Recombinant Proteins | 2 | 2001 | 1355 | 0.070 |
Why?
| | Growth Substances | 2 | 1998 | 148 | 0.070 |
Why?
| | Mevalonic Acid | 2 | 1997 | 14 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2011 | 694 | 0.070 |
Why?
| | Geranyltranstransferase | 1 | 2007 | 3 | 0.070 |
Why?
| | Potassium Chloride | 1 | 2007 | 42 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 150 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 183 | 0.060 |
Why?
| | Time Factors | 3 | 2011 | 6869 | 0.060 |
Why?
| | 3T3-L1 Cells | 1 | 2005 | 37 | 0.060 |
Why?
| | MEF2 Transcription Factors | 1 | 2005 | 59 | 0.060 |
Why?
| | Macromolecular Substances | 2 | 1996 | 226 | 0.060 |
Why?
| | Tumor Cells, Cultured | 3 | 2002 | 956 | 0.060 |
Why?
| | Fibroblasts | 3 | 2001 | 1002 | 0.060 |
Why?
| | Amino Acid Sequence | 2 | 2001 | 2159 | 0.060 |
Why?
| | Diet, Reducing | 1 | 2005 | 91 | 0.060 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2004 | 44 | 0.060 |
Why?
| | PPAR gamma | 1 | 2005 | 180 | 0.060 |
Why?
| | Lysophospholipids | 2 | 2001 | 80 | 0.050 |
Why?
| | Garlic | 1 | 2003 | 3 | 0.050 |
Why?
| | Sulfinic Acids | 1 | 2003 | 7 | 0.050 |
Why?
| | Blotting, Western | 2 | 2003 | 1232 | 0.050 |
Why?
| | Insulin Antagonists | 1 | 2002 | 7 | 0.050 |
Why?
| | Mitogens | 1 | 2001 | 59 | 0.050 |
Why?
| | DNA, Neoplasm | 1 | 2002 | 158 | 0.040 |
Why?
| | Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2001 | 12 | 0.040 |
Why?
| | Shc Signaling Adaptor Proteins | 1 | 2001 | 12 | 0.040 |
Why?
| | GRB2 Adaptor Protein | 1 | 2001 | 13 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2003 | 259 | 0.040 |
Why?
| | Plant Extracts | 1 | 2003 | 209 | 0.040 |
Why?
| | CHO Cells | 1 | 2001 | 167 | 0.040 |
Why?
| | RNA, Messenger | 2 | 1999 | 2815 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2007 | 792 | 0.040 |
Why?
| | Cricetinae | 1 | 2001 | 297 | 0.040 |
Why?
| | Phosphates | 1 | 2001 | 180 | 0.040 |
Why?
| | Glucosamine | 1 | 2000 | 15 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2001 | 533 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2001 | 310 | 0.040 |
Why?
| | Maleates | 1 | 2000 | 4 | 0.040 |
Why?
| | Cell Movement | 2 | 2003 | 969 | 0.040 |
Why?
| | Kainic Acid | 1 | 2000 | 34 | 0.040 |
Why?
| | Adenoviridae | 1 | 2001 | 200 | 0.040 |
Why?
| | Fetal Diseases | 1 | 2001 | 177 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2000 | 309 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 2 | 2001 | 663 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2001 | 239 | 0.040 |
Why?
| | Weight Loss | 1 | 2005 | 783 | 0.040 |
Why?
| | Muscle Denervation | 1 | 1999 | 9 | 0.040 |
Why?
| | Aurothioglucose | 1 | 1999 | 7 | 0.040 |
Why?
| | Clenbuterol | 1 | 1999 | 4 | 0.040 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 1999 | 5 | 0.040 |
Why?
| | Rats, Zucker | 1 | 1999 | 33 | 0.040 |
Why?
| | rab4 GTP-Binding Proteins | 1 | 1999 | 9 | 0.040 |
Why?
| | Mice, Obese | 1 | 1999 | 67 | 0.040 |
Why?
| | Dogs | 1 | 2000 | 425 | 0.040 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 1998 | 80 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2000 | 5801 | 0.040 |
Why?
| | Endothelial Growth Factors | 1 | 1998 | 65 | 0.040 |
Why?
| | Lymphokines | 1 | 1998 | 133 | 0.040 |
Why?
| | Cell Cycle | 1 | 2001 | 593 | 0.040 |
Why?
| | Progesterone | 1 | 2000 | 258 | 0.040 |
Why?
| | Blood Glucose | 2 | 1999 | 2241 | 0.040 |
Why?
| | Female | 9 | 2005 | 74016 | 0.030 |
Why?
| | Guanosine Diphosphate | 1 | 1997 | 21 | 0.030 |
Why?
| | Half-Life | 1 | 1997 | 146 | 0.030 |
Why?
| | Rats, Wistar | 1 | 1998 | 453 | 0.030 |
Why?
| | Biological Transport | 1 | 1998 | 403 | 0.030 |
Why?
| | Humans | 12 | 2016 | 138972 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2000 | 357 | 0.030 |
Why?
| | Biosynthetic Pathways | 1 | 2016 | 25 | 0.030 |
Why?
| | Inositol 1,4,5-Trisphosphate | 1 | 1996 | 21 | 0.030 |
Why?
| | Organophosphonates | 1 | 1997 | 99 | 0.030 |
Why?
| | Simvastatin | 1 | 2016 | 63 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 1999 | 254 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2005 | 2591 | 0.030 |
Why?
| | Chromatography, Gel | 1 | 1996 | 129 | 0.030 |
Why?
| | Swine | 1 | 1998 | 800 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2016 | 117 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 1998 | 550 | 0.030 |
Why?
| | Molecular Weight | 1 | 1996 | 326 | 0.030 |
Why?
| | Immunoblotting | 1 | 1996 | 309 | 0.030 |
Why?
| | Cytosol | 1 | 1996 | 229 | 0.030 |
Why?
| | Cholesterol | 1 | 2016 | 403 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1996 | 557 | 0.030 |
Why?
| | Body Weight | 1 | 1999 | 996 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 1996 | 231 | 0.030 |
Why?
| | Binding Sites | 1 | 1996 | 1317 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2000 | 3029 | 0.020 |
Why?
| | Metformin | 1 | 1996 | 331 | 0.020 |
Why?
| | Lipids | 1 | 2016 | 675 | 0.020 |
Why?
| | DNA | 1 | 1998 | 1441 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2003 | 316 | 0.020 |
Why?
| | Mutation | 1 | 2002 | 3984 | 0.020 |
Why?
| | Luciferases | 2 | 2000 | 150 | 0.020 |
Why?
| | Adult | 4 | 2016 | 38393 | 0.020 |
Why?
| | Genes, Reporter | 2 | 2000 | 274 | 0.020 |
Why?
| | Cattle | 2 | 2003 | 990 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2003 | 2516 | 0.020 |
Why?
| | Male | 3 | 2016 | 68250 | 0.020 |
Why?
| | Leucine | 1 | 2007 | 116 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2000 | 2047 | 0.020 |
Why?
| | Middle Aged | 3 | 2005 | 33782 | 0.010 |
Why?
| | Imidazoles | 1 | 2007 | 239 | 0.010 |
Why?
| | Basal Metabolism | 1 | 2005 | 62 | 0.010 |
Why?
| | Dietary Carbohydrates | 1 | 2005 | 154 | 0.010 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2003 | 11 | 0.010 |
Why?
| | Oncogene Protein v-akt | 1 | 2003 | 25 | 0.010 |
Why?
| | Fasting | 1 | 2005 | 283 | 0.010 |
Why?
| | Dietary Fats | 1 | 2005 | 301 | 0.010 |
Why?
| | Breast | 1 | 2003 | 158 | 0.010 |
Why?
| | Energy Intake | 1 | 2005 | 506 | 0.010 |
Why?
| | Cyclin D | 1 | 2001 | 9 | 0.010 |
Why?
| | Cyclin E | 1 | 2001 | 25 | 0.010 |
Why?
| | Receptors, Progesterone | 1 | 2003 | 349 | 0.010 |
Why?
| | Somatostatin | 1 | 2001 | 58 | 0.010 |
Why?
| | Fatty Acid Synthases | 1 | 2001 | 24 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2001 | 51 | 0.010 |
Why?
| | Glucose Transporter Type 4 | 1 | 2001 | 40 | 0.010 |
Why?
| | Fetal Weight | 1 | 2001 | 55 | 0.010 |
Why?
| | Cyclins | 1 | 2001 | 92 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2001 | 241 | 0.010 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2001 | 200 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 2003 | 437 | 0.010 |
Why?
| | Serum Response Factor | 1 | 2000 | 32 | 0.010 |
Why?
| | Infusions, Intravenous | 1 | 2001 | 411 | 0.010 |
Why?
| | Maternal-Fetal Exchange | 1 | 2001 | 167 | 0.010 |
Why?
| | Response Elements | 1 | 2000 | 90 | 0.010 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2001 | 131 | 0.010 |
Why?
| | Glycation End Products, Advanced | 1 | 2000 | 83 | 0.010 |
Why?
| | Leukocytes | 1 | 2001 | 308 | 0.010 |
Why?
| | Diabetic Angiopathies | 1 | 2001 | 250 | 0.010 |
Why?
| | DNA Replication | 1 | 2001 | 238 | 0.010 |
Why?
| | Leptin | 1 | 2001 | 242 | 0.010 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 209 | 0.010 |
Why?
| | MAP Kinase Signaling System | 1 | 2001 | 322 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2005 | 927 | 0.010 |
Why?
| | Sheep | 1 | 2001 | 864 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2000 | 376 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 2000 | 462 | 0.010 |
Why?
| | Farnesol | 1 | 1997 | 6 | 0.010 |
Why?
| | Adipose Tissue | 1 | 2001 | 645 | 0.010 |
Why?
| | Fetus | 1 | 2001 | 800 | 0.010 |
Why?
| | Phospholipase D | 1 | 1996 | 8 | 0.010 |
Why?
| | Egtazic Acid | 1 | 1996 | 40 | 0.010 |
Why?
| | Body Mass Index | 1 | 2005 | 2390 | 0.010 |
Why?
| | Organophosphorus Compounds | 1 | 1997 | 78 | 0.010 |
Why?
| | Type C Phospholipases | 1 | 1996 | 73 | 0.010 |
Why?
| | Diglycerides | 1 | 1996 | 61 | 0.010 |
Why?
| | Chelating Agents | 1 | 1996 | 74 | 0.010 |
Why?
| | Meiosis | 1 | 1996 | 84 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2000 | 707 | 0.010 |
Why?
| | Phosphatidylcholines | 1 | 1996 | 136 | 0.010 |
Why?
| | Heparin | 1 | 1996 | 258 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2000 | 1471 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2000 | 1473 | 0.010 |
Why?
| | Transcription Factors | 1 | 2001 | 1701 | 0.010 |
Why?
| | Prospective Studies | 1 | 2003 | 7661 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2001 | 4316 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2005 | 10921 | 0.010 |
Why?
| | Pregnancy | 1 | 2001 | 6870 | 0.000 |
Why?
| | Aged | 1 | 2003 | 24172 | 0.000 |
Why?
|
|
Goalstone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|